A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation

Journal of Thrombosis and Thrombolysis

Volumn 38, Issue 1, 2014, Pages 39-44

  Yap, Lok Bin ^a   Rusani, Beni Isman ^a   Umadevan, Dhanan ^a   Muhammad, Zulkeflee ^a   Hussin, Azlan ^a   Kaur, Surinder ^a   Omar, Razali ^a  

^a NATIONAL HEART INSTITUTE   (Malaysia)

Author keywords

Dabigatran; Non valvular atrial fibrillation; Novel anticoagulant; Stroke prevention; Warfarin

Indexed keywords

ANTITHROMBOCYTIC AGENT; DABIGATRAN ETEXILATE; RIVAROXABAN; WARFARIN; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DABIGATRAN;

ABLATION THERAPY; ADULT; ADVERSE OUTCOME; AGED; ALLERGY; ARTICLE; ASIAN; BLEEDING; BRAIN HEMORRHAGE; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DIET RESTRICTION; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPEPSIA; DYSPNEA; EPISTAXIS; FATIGUE; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GENERALIZED PAIN; GINGIVA BLEEDING; GLOMERULUS FILTRATION RATE; HAS BLED SCORE; HEADACHE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HEMATURIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN; PATIENT PREFERENCE; PEPTIC ULCER; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RETINA HEMORRHAGE; RETROSPECTIVE STUDY; SCORING SYSTEM; SWEAT GLAND DISEASE; THORAX PAIN; TREMOR; VERTIGO; VERY ELDERLY; YOUNG ADULT; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; CHEMICALLY INDUCED; COMPLICATION; MIDDLE AGED; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE;

EID: 84902381624     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1020-y     Document Type: Article

References (19)

1. Boehringer Ingelheim. Pradaxa 110 mg: summary of product characteristics. http://www.medicines.org.uk/emc/medicine/20760 Accessed 22 Oct 2013
2. Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY). N Engl J Med 361:1139-1151
3. Connolly SJ, Wallentin L, Ezekowitz MD et al (2013) The long term multi-center observational study of dabigatran treatment in patients with atrial fibrillation: (RELY-ABLE) study. Circulation 128(3):237-243
4. Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (with supplementary appendix). N Engl J Med 365:883-891
5. Granger CB, Alexander JH, McMurray JJV et al (2011) Apixaban versus warfarin in patients with atrial fibrillation (including supplementary appendix and study protocol). N Engl J Med 365:981-992
6. Camm AJ, Lip GYH, De Caterina R et al (2012) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 14:1385-1413
7. Camm J, Kirchhof P, Lip G et al (2010) Guidelines for the management of atrial fibrillation. The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369-2429
8. Shen AY, Yao JF, Brar SS et al (2007) Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50(4):309-315 (Pubitemid 47061504)
9. Guo Y, Pisters R, Apostolakis S et al (2013) Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact? Int J Cardiol 168(1):515-522
10. Truumees E, Gaudu T, Dieterichs C et al (2012) Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran). Spine 37:E863-E865
11. Wychowski MK, Kouides PA (2012) Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment. Ann Pharmacother 46:e10
12. Flaker G, Ezekowitz M, Yusuf S et al (2012) Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RELY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study. J Am Coll Cardiol 59(9):854-855
13. Lakkireddy D, Reddy YM, Di Biase L et al (2012) Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol 59(13):1168-1174
14. Nagarakanti R, Ezekowitz MD, Oldgren J et al (2011) Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation 123(2):131-136
15. Hori M, Connolly SJ, Zhu J, The RE-LY Investigators et al (2013) Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and Non-Asians with atrial fibrillation. Stroke 44(7):1891-1896
16. Wallentin L, Yusuf S, Ezekowitz MD, RE-LY investigators et al (2010) Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 376(9745):975-983
17. Ho JC, Chang AM, Yan BP, Yu CM, Lam YY, Lee VW (2012) Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong. Clin Cardiol 35(12):E40-E45
18. Larsen TB, Rasmussen LH, Skjøth F et al (2013) Efficacy and safety of dabigatran etexilate and warfarin in 'real world' patients with atrial fibrillation: A prospective nationwide cohort study. J Am Coll Cardiol 61(22):2264-2273
19. Michel J, Mundell D, Boga T et al (2013) Dabigatran for anticoagulation in atrial fibrillation - early clinical experience in a hospital population and comparison to trial data. Heart Lung Circ 22:50-55